Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1

J Clin Microbiol. 2001 Jan;39(1):357-61. doi: 10.1128/JCM.39.1.357-361.2001.

Abstract

A group of 76 consecutive human immunodeficiency virus (HIV)-positive patients with fever of unknown origin (n = 52) or fever associated with pulmonary diseases was evaluated in order to assess the usefulness of PCR with peripheral blood in the diagnosis and follow-up of visceral leishmaniasis. We identified 10 cases of visceral leishmaniasis among the 52 patients with fever of unknown origin. At the time of diagnosis, all were parasitemic by PCR with peripheral blood. During follow-up, a progressive decline in parasitemia was observed under therapy, and all patients became PCR negative after a median of 5 weeks (range, 6 to 21 weeks). However, in eight of nine patients monitored for a median period of 88 weeks (range, 33 to 110 weeks), visceral leishmaniasis relapsed, with positive results by PCR with peripheral blood reappearing 1 to 2 weeks before the clinical onset of disease. Eight Leishmania infantum and two Leishmania donovani infections were identified by PCR-restriction fragment length polymorphism analysis. PCR with peripheral blood is a reliable method for diagnosis of visceral leishmaniasis in HIV-infected patients. During follow-up, it substantially reduces the need for traditional invasive tests to assess parasitological response, while a positive PCR result is predictive of clinical relapse.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Animals
  • DNA, Protozoan / blood
  • Female
  • HIV Infections / complications*
  • HIV-1*
  • Humans
  • Leishmania donovani / genetics
  • Leishmania donovani / isolation & purification
  • Leishmania infantum / genetics
  • Leishmania infantum / isolation & purification
  • Leishmaniasis, Visceral / complications
  • Leishmaniasis, Visceral / diagnosis*
  • Leishmaniasis, Visceral / parasitology*
  • Male
  • Middle Aged
  • Polymerase Chain Reaction / methods*
  • Polymorphism, Restriction Fragment Length
  • Prognosis

Substances

  • DNA, Protozoan